VERAPAMIL, a synthetic papaverine derivative, was initially introduced as a potent peripheral and coronary vasodilator. 2 It was later found to have significant antiarrhythmic activity,8 the mechanism of which was related to selective inhibition of transmembrane fluxes of calcium.4-9 The main electrophysiologic effects of verapamil include slowing of conduction and prolongation of refractoriness in the atrioventricular node without significantly affecting intraatrial or intraventricular conduction.10-18 Thus, verapamil has been effective in the acute termination of reentrant tachycardia involving the atrioventricular node and slowing the ventricular response during atrial fibrillation or flutter in patients without preexcitation."4-'7
The effects of verapamil on accessory atrioventricular pathways in the Wolff-Parkinson-White syndrome are not well established. Although Spurrell et al.'8 reported that verapamil has minimal effects, other investigators have suggested that verapamil may shorten refractoriness of the accessory pathway. 19' 20 We determined the effects of verapamil on the electrophysiologic properties of the accessory pathway in a series of patients with the Wolff-Parkinson-White syndrome.
Methods

Patient Population
The study population consisted of eight patients referred to University Hospital for the assessment of recurrent tachycardia (table 1). All had characteristic electrocardiographic features of the Wolff-Parkinson-White syndrome: PR interval of 0.12 msec or less, A wave and QRS duration of 0.10 msec or more. Seven patients had ECG-documented supraventricular tachycardia. One of these patients also had documented episodes of intermittent atrial fibrillation. One patient gave a history of recurrent short episodes of palpitation without electrocardiographic documentation.
Electrophysiologic Studies
All patients underwent an electrophysiologic study in the nonsedated, postabsorptive state after they gave written, informed consent. Antiarrhythmic agents were discontinued at least 48 hours before the study. Four electrode catheters, three quadripolar and one tripolar, were introduced transvenously and positioned in each of the high right atrium, coronary sinus, right ventricular apex and across the septal leaflet of the tricuspid valve for His bundle recording. Intracardiac recordings were made simultaneously with leads 1, 2, 3, V, and V8 of the surface ECG on a 16-channel Elema Mingograph at a paper speed of 100 mm/sec. Programmed stimulation was carried out using a stimulator that delivered square-wave stimuli at one and one-half to two times diastolic threshold.
Standard methods for determination of atrioventricular conduction and refractoriness were used. 21, 22 If atrial fibrillation did not occur during the study, it was induced by rapid atrial pacing (cycle length 200-50 msec; pulse duration 2-4 msec; stimulus intensity two or three times threshold) and recorded for at least 2 minutes.
After determining baseline electrophysiologic measurements, verapamil, 0.15 mg/kg, was given as an i.v. bolus over 2 minutes, followed by a continuous infusion of verapamil at a rate of 0.005 mg/kg/min. The electrophysiologic study was then repeated. The retrograde effective refractory period of the accessory pathway was defined as the longest V1V2 interval that failed to conduct to the atrium over the accessory pathway, (VIV2 represents the ventricular electrogram of the last drive beat and premature beat, measured at the ventricular site closest to the accessory pathway).
Mean ventricular rate during atrial fibrillation was determined by averaging over 120 seconds. Percent preexcitation was the ratio of preexcited beats to the number of ventricular complexes during atrial fibrillation.
Participation of the accessory pathway in observed reciprocating tachycardia was determined by criteria described previously.24
Statistical Analysis
Intervals in atrial fibrillation and functional properties of the accessory pathway before and after verapamil were compared using the t test for paired data.
Results
Mechanism of Induced Arrhythmias
All patients had accessory atrioventricular pathways of the Kent type.2' One patient had two accessory pathways (table 1) . Sustained reciprocating tachycardia could be reproducibly initiated by programmed stimulation in seven patients. In all instances, the atrioventricular node participated as the antegrade limb and the accessory pathway as the retrograde limb of the reentrant circuit.2'
Atrial fibrillation was induced in all patients. In one patient atrial fibrillation was induced during atrial catheter manipulation. In the other seven, rapid atrial pacing was required. Spontaneous degeneration of reciprocating tachycardia to atrial fibrillation was observed in one patient. Atrial fibrillation terminated spontaneously in all patients before verapamil.
Effect of Verapamil on the Accessory Pathway
Functional properties of the accessory pathway could be determined in five of eight patients after verapamil infusion (table 2). The antegrade effective refractory period of the accessory pathway decreased in three patients and was unchanged in two ( fig. 1A) . The retrograde effective refractory period of the accessory pathway decreased in two patients, was unchanged in one patient and could not be determined in the rest ( fig. IB) . Antegrade conduction over the accessory pathway was enhanced in two patients and was unchanged in three patients ( fig. 1C) . Retrograde conduction over the accessory pathway was enhanced in two patients and unchanged in three ( fig. 1D ).
The changes in these measurements for the group were not statistically significant.
Effect of Verapamil on Induced Arrhythmias
Verapamil terminated reciprocating tachycardia within 10 minutes in all patients with this arrhythmia. Tachycardia was terminated in all instances by development of block in the atrioventricular node.
After verapamil, atrial fibrillation was induced in two patients by a single atrial extrastimulus during antegrade refractory period determination. Rapid atrial pacing was required in the others. In contrast to the control study, atrial fibrillation remained sustained in four patients, requiring interventions for symptomatic or hemodynamic deterioration. Two patients required cardioversion and two were given additional antiarrhythmic drugs (disopyramide and procainamide).
The average ventricular response during atrial fibrillation increased in four patients after verapamil (table 3, fig. 2A ). In these patients, the QRS morphology became predominantly preexcited and there was a 50 msec or greater decrease in the shortest RR interval between preexcited complexes.
Of the remaining four patients, verapamil slowed the average ventricular response in three and did not affect it in one patient ( Our data demonstrate that verapamil can shorten the refractory period of the accessory pathway. Most significantly, half of our patients demonstrated an increase in ventricular response during atrial fibrillation, accompanied by a decrease of the shortest RR interval between preexcited beats. Atrial fibrillation that was self-terminating in four of the eight patients before verapamil became sustained after the medication, and required cardioversion in two patients.
There are several explanations for the acceleration of ventricular response during atrial fibrillation after verapamil. First, verapamil could favor conduction over the accessory pathway by slowing conduction over the atrioventricular node and decreasing concealed, retrograde conduction into the accessory pathway by normally conducted beats.26 This was probably the case in patients with both normally conducted and preexcited beats during atrial fibrillation 
